Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$391,661
-$45,263 QoQ
Shares Held
16,265
+4.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,923
of 2,820 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MAGNOLIA CAPITAL ADVISORS LLC holds $19,446,017 across 8 Drug Manufacturers - General names. PFE ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,906 | $5,884,404 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,718 | $4,461,263 | |
| 3 | ABBV |
AbbVie Inc.
|
16,722 | $4,207,924 | |
| 4 | JNJ |
Johnson & Johnson
|
11,815 | $3,000,655 | |
| 5 | AMGN |
Amgen Inc
|
2,427 | $878,865 | |
| 6 | PFE |
Pfizer Inc
This page
|
16,265 | $391,661 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,020 | $381,546 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,160 | $239,699 |
All Filings in PFE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $391,661 | 16,265 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $436,924 | 15,560 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $316,528 | 12,712 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $262,010 | 10,283 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $267,052 | 11,017 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $272,886 | 10,769 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $541,769 | 20,421 | Shares | Sole | 2025-05-13 | |
| 2024-09-30 | $244,427 | 8,446 | Shares | Sole | 2024-10-30 | |
| 2023-06-30 | $454,465 | 12,390 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $493,965 | 12,107 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $630,610 | 12,307 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $531,027 | 12,135 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $708,591 | 13,515 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $766,920 | 14,814 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $862,897 | 14,613 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $593,882 | 13,808 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $601,967 | 15,372 | Shares | Sole | 2021-07-29 | |
| 2020-12-31 | $493,106 | 13,396 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $486,678 | 13,261 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $460,056 | 14,069 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $595,450 | 18,243 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||